The Galegenimab Biosimilar Anti-HTRA1 Antibody (AB10023) is a cutting-edge research tool designed for the study of HTRA1, a serine protease implicated in a variety of diseases including cancer, age-related macular degeneration, and neurodegenerative disorders. This polyclonal antibody, produced using state-of-the-art technology, has been validated for use in various applications, including immunoprecipitation, immunofluorescence, and flow cytometry.HTRA1, also known as high-temperature requirement A serine peptidase 1, is a key player in proteolytic processes and has been identified as a potential therapeutic target in multiple pathological conditions. By specifically binding to HTRA1, this antibody enables researchers to investigate its expression, localization, and function in different cell types and tissues.
This is particularly valuable for studies focused on understanding the role of HTRA1 in disease progression and identifying potential treatment strategies targeting this enzyme.Overall, the Galegenimab Biosimilar Anti-HTRA1 Antibody provides a reliable tool for exploring the biology of HTRA1 and its potential implications in various disease processes. Its high specificity and sensitivity make it a valuable asset for researchers in the fields of oncology, ophthalmology, and neurology, offering new insights into the mechanisms underlying these complex disorders.
Product Name:
Galegenimab (Anti-HTRA1) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0130
Target:
HTRA1
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
FHTR2163, RG-6147, RG6417, RO-7171009, RO7171009
Description:
Anti-HTRA1(galegenimab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
